Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer
Open Access
- 8 March 2021
- Vol. 13 (5), 1163
- https://doi.org/10.3390/cancers13051163
Abstract
Head and neck cancer (HNC) is a significantly heterogeneous disease and includes malignancies arising from different anatomical sites, such as nasopharyngeal cancer (NPC) and laryngeal cancer (LC). In the current study, polymorphisms located in angiogenesis- and apoptosis-related genes (VEGFA, FAS, EDNRA and NBS1) were evaluated regarding their clinical significance in HNC patients. In total, 333 HNC patients were enrolled in this study and 34 variants located on the aforementioned genes were genotyped via Sanger sequencing. LC patients, homozygous A for VEGFA rs13207351, had shorter overall survival (OS) as opposed to homozygous G (Hazard ratio (HR) = 2.06, Wald’s p = 0.017) upon adjustment for age, disease stage, and surgery. Following the dominant model, LC patients carrying the A allele had a marginally significantly higher risk for death (HR = 1.72, p = 0.059). NPC patients heterozygous (CT) for FAS rs2234768 had a marginal but significantly higher risk of death compared to those with homozygosity for the T allele (HR = 2.22, p = 0.056). In conclusion, rs13207351 (VEGFA) and rs2234768 (FAS) polymorphisms seem to have prognostic significance in HNC, with VEGFA rs13207351 showing the most promise in this subgroup of LC patients.Funding Information
- Hellenic Cooperative Oncology Group (N/A)
This publication has 60 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Nijmegen breakage syndrome (NBS)Orphanet Journal of Rare Diseases, 2012
- FAS-670A/G polymorphism: A biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese populationClinica Chimica Acta; International Journal of Clinical Chemistry, 2010
- Total Exposure and Exposure Rate Effects for Alcohol and Smoking and Risk of Head and Neck Cancer: A Pooled Analysis of Case-Control StudiesAmerican Journal of Epidemiology, 2009
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumorsMolecular Cancer Therapeutics, 2009
- Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and TreatmentAnnual review of pathology, 2009
- Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesisHead & Neck, 2008
- The Human Genome Browser at UCSCGenome Research, 2002
- Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and NeckThe New England Journal of Medicine, 2001
- Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal TumorsThe American Journal of Pathology, 2000